Observational Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Aug 21, 2020; 26(31): 4703-4717
Published online Aug 21, 2020. doi: 10.3748/wjg.v26.i31.4703
Table 1 Characteristics of healthy controls and chronic hepatitis B and hepatitis B virus-related liver failure patients
Clinical parametersHCCHBHBV-related liver failure
Number404855
Age in yr47.05 ± 14.7041.63 ± 13.0847.89 ± 11.04
Male, n242737
ALT in U/L16.55 ± 5.43327.52 ± 312.57549.60 ± 686.13bc
AST in U/L22.95 ± 5.70176.58 ± 208.19487.55 ± 571.49be
Total bilirubin in μmol/L12.48 ± 3.2325.65 ± 43.43302.52 ± 144.84bf
Albumin in g/L42.98 ± 2.3242.36 ± 3.9931.01 ± 4.06bf
Prealbumin in mg/LNA109.17 ± 68.43174.09 ± 81.47d
Cholinesterase in U/LNA6536.11 ± 2543.803214.65 ± 1663.35f
Prothrombin time in sNANA25.44 ± 8.30
International normalized ratioNANA2.22 ± 0.74
Prothrombin activity as %NANA29.87 ± 9.09
Leucocyte as × 109/L5.77 ± 1.605.01 ± 1.306.74 ± 4.18c
Lymphocyte number as × 109/L2.64 ± 0.731.70 ± 0.603.08 ± 5.40
Blood platelets as × 109/L194.68 ± 41.53157.52 ± 67.5397.96 ± 52.06bf
Creatinine in μmol/LNA63.08 ± 13.2496.69 ± 123.50
hs-CRP in mg/dLNANA20.04 ± 29.97
Log HBV DNA in IU/mLNA6.81 ± 1.335.27 ± 1.79f